Corporate insider profile
Robert C. Goeltz II Insider Trades
Robert C. Goeltz II has reported no open-market purchases on SEC Form 4 and is a net seller of $198,966 across 1 company. The most recent open-market transaction was reported on May 11, 2026. Source: SEC Form 4 filings.
Latest reported as Chief Financial Officer of Arcus Biosciences, Inc. (RCUS).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$198,965.69
- Latest transaction
- May 11, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Robert C. Goeltz II insider trading FAQ
- Is Robert C. Goeltz II buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Robert C. Goeltz II is a net seller of $198,966, with no open-market purchases reported. The latest transaction was reported on May 11, 2026.
- Which companies does Robert C. Goeltz II report insider trades for?
- Robert C. Goeltz II has reported open-market trades in Arcus Biosciences, Inc. (RCUS). The latest SEC-reported relationship is Chief Financial Officer of Arcus Biosciences, Inc. (RCUS).
- Where does Robert C. Goeltz II's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1653881, and refreshes this page daily.
